Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey. Show more

2 Headquarters Plaza, Morristown, NJ, 07960, United States

Biotechnology

Healthcare

Start AI Chat

Market Cap

141.4M

52 Wk Range

$1.39 - $3.77

Previous Close

$3.00

Open

$3.02

Volume

85,535

Day Range

$2.95 - $3.19

Enterprise Value

-85.77M

Cash

162.6M

Avg Qtr Burn

-15.38M

Insider Ownership

12.43%

Institutional Own.

76.06%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
HWK-007 Details NSCLC, ovarian, endometrial cancers	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HWK-016 (MUC16 Targeted ADC) Details Ovarian And Endometrial Cancers	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.